文献速递泌尿生殖与妇科肿瘤放疗

宫颈癌患者接受10 Gy放射治疗后组织中钙网蛋白表达上调

Calreticulin Upregulation in Cervical Cancer Tissues From Patients After 10 Gy Radiation Therapy.
PubMed 文献 · Adv Radiat Oncol · 2022-12-27

该回顾性分析纳入67例接受根治性放疗的宫颈鳞状细胞癌患者,比较放疗前与10 Gy照射后肿瘤组织中钙网蛋白表达变化。结果显示82%患者钙网蛋白表达显著增加(P<.01),钙网蛋白升高者无进展生存期有改善趋势但未达统计学显著(P=.09),高表达组中钙网蛋白与CD8+ T细胞密度呈正相关趋势但亦未达显著(P=.06)。

要点

  • 宫颈鳞癌患者10 Gy照射后82%出现钙网蛋白表达增加,差异有统计学意义(P<.01)。
  • 钙网蛋白升高者无进展生存期有改善趋势,但未达统计学显著(P=.09)。
  • 高表达组中钙网蛋白与CD8+ T细胞密度呈正相关趋势,但未达统计学显著(P=.06)。

核心结论

  • 宫颈癌患者组织活检在10 Gy照射后钙网蛋白表达增加。
  • 较高的钙网蛋白表达水平可能与更好的无进展生存期和更高的T细胞阳性率相关,但钙网蛋白上调与临床结局或CD8+ T细胞密度之间无统计学显著关系。
  • 需要进一步分析以阐明放疗免疫反应机制并优化放疗与免疫联合方案。

研究设计与样本

  • 回顾性分析纳入67例接受根治性放疗的宫颈鳞状细胞癌患者。
  • 放疗前及10 Gy照射后采集肿瘤活检标本,采用免疫组化染色评估肿瘤细胞钙网蛋白表达。
  • 按钙网蛋白表达水平将患者分为2组并比较临床结局,同时评估钙网蛋白水平与间质CD8+ T细胞密度的相关性。

主要发现

  • 10 Gy照射后钙网蛋白表达显著增加,82%的患者显示增加(P<.01)。
  • 钙网蛋白升高患者无进展生存期有改善趋势,但未达统计学显著(P=.09)。
  • 钙网蛋白高表达患者中钙网蛋白与CD8+ T细胞密度呈正相关趋势,但关联未达统计学显著(P=.06)。

关键数值与推荐

  • 钙网蛋白表达增加:82%的患者(P<.01)。
  • 无进展生存期比较:P=.09。
  • 钙网蛋白与CD8+ T细胞密度相关性:P=.06。

局限性

  • 原文指出需要进一步分析以阐明放疗免疫反应机制并优化放疗与免疫联合方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Understanding the immune response during radiation therapy (RT) in a clinical setting is imperative for maximizing the efficacy of combined RT and immunotherapy. Calreticulin, a major damage-associated molecular pattern that is exposed on the cell surface after RT, is presumed to be associated with the tumor-specific immune response. Here, we examined changes in calreticulin expression in clinical specimens obtained before and during RT and analyzed its relationship with the density of CD8+ T cells in the same patient set. METHODS AND MATERIALS: This retrospective analysis evaluated 67 patients with cervical squamous cell carcinoma who were treated with definitive RT. Tumor biopsy specimens were collected before RT and after 10 Gy irradiation. Calreticulin expression in tumor cells was evaluated via immunohistochemical staining. Subsequently, the patients were divided into 2 groups according to the level of calreticulin expression, and the clinical outcomes were compared. Finally, the correlation between calreticulin levels and density of stromal CD8+ T cells was evaluated. RESULTS: The calreticulin expression significantly increased after 10 Gy (82% of patients showed an increase; P < .01). Patients with increased calreticulin levels tended to show better progression-free survival, but this was not statistically significant (P = .09). In patients with high expression of calreticulin, a positive trend was observed between calreticulin and CD8+ T cell density, but the association was not statistically significant (P = .06). CONCLUSIONS: Calreticulin expression increased after 10 Gy irradiation in tissue biopsies of patients with cervical cancer. Higher calreticulin expression levels are potentially associated with better progression-free survival and greater T cell positivity, but there was no statistically significant relationship between calreticulin upregulation and clinical outcomes or CD8+ T cell density. Further analysis will be required to clarify mechanisms underlying the immune response to RT and to optimize the RT and immunotherapy combination approach.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Okada K, Sato H, Kumazawa T, et al. Calreticulin Upregulation in Cervical Cancer Tissues From Patients After 10 Gy Radiation Therapy. Adv Radiat Oncol. 2022. PMID: 36793509. doi:10.1016/j.adro.2022.101159

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。